Biomerica, Inc. is a biomedical technology company that develops, patents, manufactures and markets advanced diagnostic and therapeutic products. Its diagnostic test kits are utilized in the analysis of blood, urine, nasal, or fecal samples for the diagnosis of various diseases, food intolerances, and other medical conditions. Its range of medical diagnostic products is sold primarily in two markets: clinical laboratories and point-of-care settings, including physicians’ offices and over-the-counter sales. It is focused on research and development efforts and is its patented diagnostic-guided therapy (DGT) product, developed on the in Foods technology platform. Its inFoods IBS product, uses a simple blood test to identify patient-specific foods that, when eliminated, may alleviate IBS symptoms such as pain, bloating, diarrhea, cramping, and constipation. Its hp+detect, a new diagnostic test for detecting Helicobacter pylori (H. pylori) bacteria in the gastrointestinal tract.
企業コードBMRA
会社名Biomerica Inc
上場日Mar 17, 1980
最高経営責任者「CEO」Mr. Zackary S. Irani
従業員数63
証券種類Ordinary Share
決算期末Mar 17
本社所在地17571 Von Karman Avenue
都市IRVINE
証券取引所NASDAQ Capital Market Consolidated
国United States of America
郵便番号92614
電話番号19493792875
ウェブサイトhttps://biomerica.com/
企業コードBMRA
上場日Mar 17, 1980
最高経営責任者「CEO」Mr. Zackary S. Irani
過去5年間の配当金総支払額は
0.00
米ドルである。

データなし